Physical/de facto cross-matching in order to complement its primary virtual variant prior to kidney allografting: Substantial benefit or only fishing for diagnostic artifacts?
Early genotype-based dose adjustment of tacrolimus reduces risk for de novo donor-specific HLA antibodies and rejection in CYP3A5 expressers among renal transplant patients
Donor-derived cell-free DNA: A promising non-invasive biomarker for the early detection of allograft rejection and damage in lung transplant recipients